Loading
This page follows insider dealings at TriVascular Technologies, Inc. as filed with SEC (Form 4). No insider at TriVascular Technologies, Inc. has published a filing in the past twelve months. The most recent one dates from 5 February 2016.
Other companies in the same market with recent insider buying flagged by our signals: Relmada Therapeutics, Inc. and Uber Technologies, Inc. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
25 of 53 declarations
TriVascular Technologies, Inc. is a company focused on developing medical devices for the treatment of vascular diseases. It is listed on the XNAS market.